文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

检测儿童和青少年的家族性高胆固醇血症:潜力与挑战。

Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges.

机构信息

Department of General Paediatrics, Clinical Dyslipidemia Service for the Study and Prevention of Atherosclerosis in Children, ASST-Santi Paolo E Carlo, University of Milan, Milan, Italy.

Centre for Paediatric Dyslipidaemias, Paediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, 29121, Piacenza, Italy.

出版信息

Ital J Pediatr. 2022 Jul 15;48(1):115. doi: 10.1186/s13052-022-01257-y.


DOI:10.1186/s13052-022-01257-y
PMID:35840982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9287900/
Abstract

BACKGROUND: It is now well established that atherosclerosis begins in childhood and evolves through adolescence and young adulthood, ultimately resulting in myocardial infarction and stroke in adults. MAIN TEST: Childhood is a critical phase during which atherosclerosis may begin to develop; in the presence of familial hypercholesterolemia, lifelong elevation of Low Density Lipoprotein cholesterol levels greatly accelerates atherosclerosis. These concepts, which have been largely developed from epidemiologic evidence, have not always been simple to implement in the paediatric clinical practice. The purpose of this article is to briefly review but also to highlight the rationale, the motivation and the methods in the process of identifying children and adolescents with familial hypercholesterolemia, an often hidden but very important genetic disease.

摘要

背景:现在已经确定,动脉粥样硬化始于儿童期,并在青春期和成年早期发展,最终导致成年人的心肌梗死和中风。

主要试验:儿童期是动脉粥样硬化可能开始发展的关键阶段;在家族性高胆固醇血症的情况下,低密度脂蛋白胆固醇水平的终身升高极大地加速了动脉粥样硬化的发展。这些概念主要是从流行病学证据中得出的,但在儿科临床实践中并不总是那么容易实施。本文的目的是简要回顾,但也要强调确定家族性高胆固醇血症儿童和青少年的理由、动机和方法,家族性高胆固醇血症是一种经常被隐藏但非常重要的遗传疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f23/9287900/6190c7d6d164/13052_2022_1257_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f23/9287900/6190c7d6d164/13052_2022_1257_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f23/9287900/6190c7d6d164/13052_2022_1257_Fig1_HTML.jpg

相似文献

[1]
Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges.

Ital J Pediatr. 2022-7-15

[2]
Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.

JAMA. 2016-8-9

[3]
A familial hypercholesterolemia week in Kyrgyzstan: The joint scientific and practical symposium with the European Atherosclerosis Society (EAS), the International Atherosclerosis Society (IAS) and the Kyrgyz Society of Cardiology (KSC).

Atherosclerosis. 2019-2

[4]
Statins for children with familial hypercholesterolemia.

Cochrane Database Syst Rev. 2014-7-23

[5]
Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week.

J Am Coll Cardiol. 2023-10-10

[6]
Familial hypercholesterolemia in childhood and adolescents: A hidden reality.

Clin Investig Arterioscler. 2017

[7]
Familial Hypercholesterolemia in Children and Adolescents: Diagnosis and Treatment.

Curr Pharm Des. 2018

[8]
Statins for children with familial hypercholesterolemia.

Cochrane Database Syst Rev. 2010-7-7

[9]
Familial hypercholesterolemia in children.

Curr Opin Lipidol. 2004-8

[10]
Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.

Curr Opin Lipidol. 2019-4

引用本文的文献

[1]
Fiber in the Treatment of Dyslipidemia in Pediatric Patients.

Children (Basel). 2025-3-28

[2]
Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia.

Biomolecules. 2024-12-16

[3]
Biochemical and Anthropometric Outcomes in Paediatric Patients with Heterozygous Familial Hypercholesterolemia after COVID-19 Pandemic Lockdowns: An Exploratory Analysis.

Nutrients. 2024-7-8

[4]
The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis.

Curr Atheroscler Rep. 2024-8

[5]
Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology.

Ital J Pediatr. 2023-9-8

[6]
Genetic Testing for Familial Hypercholesterolemia in a Pediatric Group: A Romanian Showcase.

Diagnostics (Basel). 2023-6-7

[7]
Hyperlipidemia and Cardiovascular Risk in Children and Adolescents.

Biomedicines. 2023-3-7

本文引用的文献

[1]
Early Prevention of Atherosclerosis: Detection and Management of Hypercholesterolaemia in Children and Adolescents.

Life (Basel). 2021-4-14

[2]
Prevention starts from the crib: the pediatric point of view on detection of families at high cardiovascular risk.

Ital J Pediatr. 2021-3-5

[3]
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia.

Atheroscler Suppl. 2020-12

[4]
Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.

Atherosclerosis. 2018-10

[5]
Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK.

Eur Heart J. 2017-6-14

[6]
Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).

Atherosclerosis. 2017-5

[7]
Documenting family history in children with hypercholesterolaemia: A lost opportunity.

J Paediatr Child Health. 2017-5

[8]
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Atherosclerosis. 2016-10

[9]
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Eur Heart J. 2015-9-21

[10]
Carotid intima-media thickness in children with familial hypercholesterolemia.

Circ Res. 2013-11-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索